Cassaday & Co Wealth Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4K Hold
11,615
﹤0.01% 332
2025
Q1
$16.7K Hold
11,615
﹤0.01% 317
2024
Q4
$25.6K Sell
11,615
-1,667
-13% -$3.67K ﹤0.01% 319
2024
Q3
$21.9K Buy
13,282
+1,667
+14% +$2.75K ﹤0.01% 311
2024
Q2
$25.8K Hold
11,615
﹤0.01% 290
2024
Q1
$31.1K Buy
+11,615
New +$31.1K ﹤0.01% 295